Letter: bias in clinical trials of the symptomatic effects of the low FODMAP diet for irritable bowel syndrome—getting the facts right. Authors' reply
- 4 July 2017
- journal article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 46 (3) , 386-387
Abstract
Linked ContentThis article is linked to Krogsgaard et al, and Gibson et al papers. To view these articles visit https://doi.org/10.1111/apt.14065 and https://doi.org/10.1111/apt.14150.Keywords
This publication has 5 references indexed in Scilit:
- Letter: bias in clinical trials of the symptomatic effects of the low FODMAP diet for irritable bowel syndrome—getting the facts rightAlimentary Pharmacology & Therapeutics, 2017
- Systematic review: quality of trials on the symptomatic effects of the low FODMAP diet for irritable bowel syndromeAlimentary Pharmacology & Therapeutics, 2017
- Design of Treatment Trials for Functional Gastrointestinal DisordersGastroenterology, 2016
- A Diet Low in FODMAPs Reduces Symptoms of Irritable Bowel SyndromeGastroenterology, 2014
- Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndromeJournal of Gastroenterology and Hepatology, 2010